Additional file 2 of Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect

MLA

J. Boegeholz, et al. Additional File 2 of Challenges in Diagnosis and Management of Neutropenia upon Exposure to Immune-Checkpoint Inhibitors: Meta-Analysis of a Rare Immune-Related Adverse Side Effect. Jan. 2020. EBSCOhost, https://doi.org/10.6084/m9.figshare.12127458.v1.

APA

J. Boegeholz, C. S. Brueggen, C. Pauli, F. Dimitriou, E. Haralambieva, R. Dummer, M. G. Manz, & C. C. Widmer. (2020). Additional file 2 of Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect. https://doi.org/10.6084/m9.figshare.12127458.v1

Chicago

J. Boegeholz, C. S. Brueggen, C. Pauli, F. Dimitriou, E. Haralambieva, R. Dummer, M. G. Manz, and C. C. Widmer. 2020. “Additional File 2 of Challenges in Diagnosis and Management of Neutropenia upon Exposure to Immune-Checkpoint Inhibitors: Meta-Analysis of a Rare Immune-Related Adverse Side Effect,” January. doi:10.6084/m9.figshare.12127458.v1.